Loading...
FAQs
A-
A+

Fonts Size

Change Color

Hit enter to search or ESC to close
A-
A+

Fonts Size

Change Color

Alert:

Healthcare facilities are required to complete the Training Programme on Abu Dhabi Healthcare Guidelines for Health Media & Advertising System as mentioned in circular number 26/2023, for more information Click Here

DOH urges all healthcare and pharmaceutical facilities & Health professional to Adhere to the circular number(63\2021) by updating the details of the mobile number & e-mail address in order to receive all circulars & letters issued by DOH, for more information Click Here

Shafafiya

Dose, Frequency and RxInstruction in PBM Prior Authorisations and Claims

DATE: 1 DECEMBER 2023

Starting from 1st December 2023 (Transaction Date), in accordance with the DOH circular USO/172/2023 Update Drug Dosage and Frequency Mandatory Submission Requirements, Shafafiya validation rules 82_42, 82_43 and 82_44 will be rejecting any Prior Request and Claim Submission transactions not compliant with related requirements. Healthcare Entities are advised to update relevant systems and start reporting of required observations in transactions as soon as possible to prepare for the DOH Inspector visits.

Related resources:

fam-sch-home

Muashir

weqaya-program

Aamen

oral-health-program

Research And Innovation Center

Subscribe for updates

Thanks for Subscribing

Last updated: 21 Dec 2024

Mobile For an optimal experience please
rotate your device to portrait mode